DIR Return Create A Forum - Home
       ---------------------------------------------------------
       MS Speaks
  HTML https://msspeaks.createaforum.com
       ---------------------------------------------------------
       *****************************************************
   DIR Return to: TREATMENTS
       *****************************************************
       #Post#: 2754--------------------------------------------------
       (Abst.) Safety and efficacy of autologous HSCT for MS in Norway
       By: agate Date: December 14, 2019, 8:59 pm
       ---------------------------------------------------------
       This is a small study (30 patients) but the finding that some
       patients had amenorrhea lasting more than 12 months and ovarian
       failure would be a concern.
       From PubMed (December 14, 2019), "Safety and efficacy of
       autologous hematopoietic stem cell transplantation for multiple
       sclerosis in Norway":
  HTML https://www.ncbi.nlm.nih.gov/pubmed/31833798
       *****************************************************